Outcomes Data of Adipose Stem Cells to Treat Rheumatoid Arthritis



Status:Recruiting
Conditions:Arthritis, Rheumatoid Arthritis
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:18 - Any
Updated:9/2/2018
Start Date:January 2015
End Date:May 2019
Contact:Holly Bergen
Phone:800-609-7795

Use our guide to learn which trials are right for you!

Autologous Adipose Stromal Vascular Fraction Outcomes in Rheumatoid Arthritis Research Study

The purpose of this study is to determine the impact that treatment with a cellular
concentrate derived from an individual's own fat, known as the stromal vascular fraction
(SVF), has on pain and functionality in people with rheumatoid arthritis (RA). SVF contains
multiple cellular components, including stem cells, with both regenerative and
anti-inflammatory properties. This therapy has shown promise for ameliorating the symptoms of
RA. This study is designed to evaluate changes in pain and functionality in individuals with
RA for up to 12 months following SVF treatment.


Inclusion Criteria:

- Subjects diagnosed with rheumatoid arthritis

- Subjects scheduled for a stem cell/SVF treatment

- Subjects willing and able to sign informed consent

- Subjects willing and able to perform follow-up interviews and surveys

Exclusion Criteria:

- Subjects with addition major health condition/disease diagnoses

- Subjects that are pregnant or breastfeeding
We found this trial at
1
site
11515 El Camino Real
San Diego, California 92121
Phone: 855-742-7836
?
mi
from
San Diego, CA
Click here to add this to my saved trials